UnitedHealth Group Inc (UNH) FinancialsUNHFinancialUnitedHealth Group Inc

UnitedHealth Group Inc (UNH) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is UnitedHealthCare, accounting for 77.2% of total sales, equivalent to $86.27B. Other significant revenue streams include Optum Rx and Optum Health. Understanding this composition is critical for investors evaluating how UNH navigates market cycles within the Managed Healthcare industry.

Evaluating the bottom line, UnitedHealth Group Inc maintains a gross margin of N/A. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 7.18%, while the net margin is 5.06%. These profitability ratios, combined with a Return on Equity (ROE) of 14.18%, provide a clear picture of how effectively UNH converts its operational activities into shareholder value.

In the context of the broader market, UNH competes directly with industry leaders such as ELV and CI. With a market capitalization of $360.59B, it holds a leading position in the sector. When comparing efficiency, UNH's gross margin of N/A stands against ELV's N/A and CI's 8.58%. Such benchmarking helps identify whether UnitedHealth Group Inc is trading at a premium or discount relative to its financial performance.

UnitedHealth has shown strong revenue growth, with total revenues reaching $113.575 billion in Q4 2025, and a net income of $6.90 per share in Q1 2026. However, net margins have been under pressure, dropping to 5.06% in Q2 2026.